Zhi Cao

Zhi Cao

Auto-generated profile, based on publicly available information

Zhi Cao


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2019 in Polymers
Verified
Journal Article
Open access
PDF file
GBGavin Burke
Gavin Burke
ZCZhi Cao
Zhi Cao
Declan M. DevineDeclan M. Devine
Declan M. Devine
Ian MajorIan Major
Ian Major
Through the control of the molecular weight, water content and monomer concentration, polyethylene glycol dimethacrylate (PEGDMA) based hydrogels have been adapted for numerous applications, including as structural scaffolds, drug delivery vehicles and cell carriers. However, due to the low biodegradability rates, the use of PEGDMA in tissue engineering has been limited. Thiol-based monomers have been shown to improve the degradation rates of several PEG-based hydrogels, though their impact on several material properties has not been as well defined. In this work, several mercaptopropianoates, as well as mercaptoacetates, were mixed with PEGDMA and copolymerized. Following an initial polymerization check, it was determined that mercaptoacetate-based thiol monomers did not polymerize in the presence of PEGDMA, whereas mercaptopropionates were more successful. The wettability, and the compressive and tensile strength, in addition to the thermal properties, were determined for successfully copolymerized samples via a combination of differential scanning calorimetry, dynamic mechanical analysis, unconfined compression, and goniometry. Further study determined that dipentaerythritol hexa(3–mercaptopropionate) (DiPETMP) successfully enhanced the biodegradability of PEGDMA.

23 November 2022 in Polymers
Verified
Journal Article
Open access
PDF file
KGKe Gong
Ke Gong
HLHandai Liu
Handai Liu
CHCheng Huang
Cheng Huang
ZCZhi Cao
Zhi Cao
EFEvert Fuenmayor
Evert Fuenmayor
Ian MajorIan Major
Ian Major
Acrylonitrile Butadiene Styrene (ABS) is a common thermoplastic polymer that has been widely employed in the manufacturing industry due to its impact resistance, tensile strength, and rigidity. Additive manufacturing (AM) is a promising manufacturing technique being used to manufacture products with complex geometries, but it is a slow process producing mechanically inferior products when compared to traditional production processes like injection molding (IM). Thus, our hybrid manufacturing (HM) process combining materials extrusion AM and IM to create a single article was investigated in this study, in which eleven batches of specimens were made and extensively tested. These include the AM, IM, and hybrid manufactured (HYM) samples, in which the HYM samples were made by inserting AM substrates into the IM tool and were varied in infill density of AM preforms and geometries. The HYM samples outperformed AM parts in terms of mechanical performance while retaining customizability dependent on the HYM processing parameters, and the best mechanical performance for HYM samples was found to be comparable to that of IM samples, implying that the overmolding process in HM had primarily improved the mechanical performance of AM products. This work leads to a deeper knowledge of applications to confirm the optimal component fabrication in high design flexibility and mass production.

10 December 2022 in Polymers
Verified
Journal Article
Open access
PDF file
KGKe Gong
Ke Gong
HLHandai Liu
Handai Liu
CHCheng Huang
Cheng Huang
QJQinyu Jiang
Qinyu Jiang
HXHan Xu
Han Xu
Ian MajorIan Major
Ian Major
Mass customization is the development of items tailored to specific customers, but produced at low unit cost in high-volume. In this context, hybrid manufacturing (HM) combines fused deposition modeling (FDM) and injection molding (IM) to fabricate a single personalized part with minimum manufacturing cost. In this technique, inserts with different physical features are first FDM-fabricated and then IM-overmolded. This study investigated the effect of hybrid FDM-IM production technology, FDM insert geometry on mechanical properties, and micro-structural evolution of Polylactic Acid (PLA) samples. The findings indicated a comparable tensile properties of FDM-IM samples (68.38 MPa) to IM batch (68.95 MPa), emphasizing the potential of HM in the manufacturing industry. Maximum tensile stress of FDM-IM specimens shows an upward trend due to the increased infill density of preforms. In addition, overmolding interface direction results in a big gap for the maximum tensile strengths between half-length series specimens (12.99 MPa to 19.09 MPa) and half-thickness series specimens (53.83 MPa to 59.92 MPa). Furthermore, four joint configurations resulted in different mechanical performances of finished specimens, in which the female cube sample exhibits the highest tensile stress (68.38 MPa), while the batch with male T joint shows a lower value in maximum tensile strength (59.51 MPa), exhibiting a similar tensile performance with the half-thickness 75% batch without joint configuration. This study lays the groundwork for using HM to produce bespoke and mechanically improved parts over FDM alone.

3 February 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
HXHan Xu
Han Xu
FMFarnoosh McDonagh
Farnoosh McDonagh
KGKe Gong
Ke Gong
ZCZhi Cao
Zhi Cao
EFEvert Fuenmayor
Evert Fuenmayor
Ian MajorIan Major
Ian Major
Since 3D printing allows for patient-specific dosage forms, it has become a major focus in pharmaceutical research. However, it is difficult to scale up drug product manufacturing. Injection molding has been used in conjunction with hot-melt extrusion to mass produce drug products, but making tailored solid dosage forms with this technology is neither cost-effective nor simple. This study explored the use of a combination of fused filament fabrication and injection molding to create patient-specific solid dosage forms. A tablet fixation and location template was used to overprint directly on injection-molded tablet bases, and theophylline was combined with polycaprolactone and Kollidon® VA64 via hot-melt extrusion to produce the filament. Dynamic mechanical analysis was used to evaluate the brittleness of the filament, and differential scanning calorimetry was used to analyze the thermal results. The results showed that theophylline had a flow promoting effect on the polymer blend and that overprinted tablets were manufactured faster than 3D-printed tablets. Drug release studies also showed that overprinted tablets released faster than injection-molded tablets. This method demonstrates the potential of hybrid manufacturing for the pharmaceutical industry as a means of bridging the gap between personalized dosage forms and mass production.